Charcot-Marie-Tooth Disease Type 1A Revealed by Vincristine Treatment.
スポンサーリンク
概要
- 論文の詳細を見る
We report the case of a 2-year-old boy with acute lymphoblastic leukemia who presented Charcot-Marie-Tooth (CMT) disease following the administration of vincristine (VCR) for acute lymphoblastic leukemia. After the patient received a total dose of 8 mg/m<SUP>2</SUP> of VCR, he demonstrated marked muscle weakness, distal muscle atrophy in the arms and legs, pes cavus, foot drops, claw hand, tremor, and diminished deep tendon reflex, suggesting the presence of CMT disease. By genetic analysis, he was shown to have duplication of the PMP22 gene, and was diagnosed as CMT type 1A. Although his mother and maternal grandmother were asymptomatic, they were also diagnosed as CMT type 1A. He has been on complete remission by chemotherapy without VCR. Care should be taken to pay attention to the possibility of masked CMT disease when administering VCR.
- 特定非営利活動法人 日本小児血液・がん学会の論文
特定非営利活動法人 日本小児血液・がん学会 | 論文
- The Parent's Emotional Adaptation to the Children's Malignant Disease
- Side Effect of Cranial Radiation in Childhood Acute Leukemia
- Red Blood Cell Volume Distribution Width in Normal Children and in the Patients with Various Kinds of Hematological Disorders.
- Effective Conditioning of Donors for Granulocyte Transfusions with Recombinant Human Granulocyte Colony-Stimulating Factor.
- Two Infant Girls of CNS Leukemia with Chronic Subdural Hematoma